Pooled 30 percent increased risk for thrombocytopenia seen after first dose of ChAdOx1-S versus BNT162b2
Overall Symptoms After BNT162b2, Other Vaccines Comparable in <5s
Injection-site, musculoskeletal, dermatologic, otolaryngologic symptoms more frequent; general symptoms and fever less frequent with BNT162b2 in children younger than 5 years of age
Blood Donations Welcomed Following Vaccinations
It is anticipated by health experts that throughout the winter of 2022-2023, there will be an increased demand for blood donations in the U.S.
The American Red Cross urges healthy donors of all blood types to give blood or platelets to ensure a strong blood supply as the Northern Hemisphere flu season begins.
And the Red Cross is sharing a vital reminder… that it's okay to give blood after getting an influenza or COVID-19 vaccination.
Excess AMI-Linked Mortality Persisted During Pandemic
Significant increases seen among youngest-aged men and women, even during omicron surge
COVID-19 Vaccine Inhaled Through the Mouth Launched in China
Advantages to inhaled vaccine include the concept of priming the area of the body where the virus often enters
55,000 Sudan Ebolavirus Vaccine Candidates Coming by Year End
The nonprofit scientific research organization IAVI and Merck & Co., Inc. announced today they have entered into an agreement that could enable IAVI to accelerate the entry of a Sudan ebolavirus (SUDV) vaccine candidate that could be deployed in the Republic of Uganda this year.
The Ministry of Health of Uganda has declared a SUDV outbreak in several districts that have claimed about 28 lives since late September 2022.
Cardiovascular Events Up for Individuals Hospitalized With COVID-19
Largest effect sizes seen for venous thromboembolism, heart failure, and stroke; risks highest in first 30 days
Highest COVID-19 Death Rate for 2020 Seen in the Most Urban Areas
Highest death rate for males seen in most urban areas, while for females, death rate was highest in most urban and most rural areas
Herpes Virus Sheds for Several Months
An Original Investigation reported concerning news for people recently diagnosed with genital herpes simplex virus type 1 (HSV-1).
The peer-review journal The JAMA Network found genital HSV-1 shedding was frequent after the first episode, particularly among individuals with primary infection.
However, HSV-1 shedding declined rapidly during the first year following infection.
Whether the decline in genital HSV-1 shedding over time is due to virologic or immunologic factors was unclear, wrote these researchers.
Flu, COVID-19 Vaccination Cover High Among Health Care Personnel
HCP who reported employer vaccination requirements had higher vaccination coverage for flu, COVID-19 primary series, COVID-19 booster